# Consort Medical PLC

Consort Medical PLC is an Asset Manager based in Hemel Hempstead, United Kingdom.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Hemel Hempstead, United Kingdom
- **Region:** Europe
- **Address:** Hemel Hempstead, United Kingdom
- **Assets under management:** Undisclosed
- **Website:** consortmedical.com
- **LinkedIn:** https://www.linkedin.com/company/consort-medical-plc

## Regulatory record

- **Reports private funds:** No

## About

Consort Medical PLC, led by CEO Jonathan Glenn and CFO Richard Cotton, operates as a contract development and manufacturing organization (CDMO) in the pharmaceutical sector. The company's history traces back to the 1970s, though its current corporate structure was established through a series of acquisitions that built its drug delivery device and respiratory product portfolio (per regulatory filings). Consort Medical focuses on two core business segments: Bespak, which designs and manufactures drug delivery devices such as inhalers, auto-injectors, and nasal spray pumps for pharmaceutical partners, and Aesica, a CDMO providing formulation development and manufacturing services for active pharmaceutical ingredients and finished dosage forms. The company serves clients across multiple therapeutic areas, including respiratory, central nervous system, and cardiovascular, with production sites in the UK, Germany, Italy, and the US (per public company documentation). Geographically, Consort Medical operates through its headquarters in Hemel Hempstead, UK, with additional offices in Schaffhausen, Switzerland; New Brunswick and Minneapolis, US; Guangzhou, China; Basel, Switzerland; Amsterdam, Netherlands; and Wien, Austria. The company employs thousands globally, though exact team size is not publicly specified. In recent years, Consort Medical has focused on expanding its capacity for high-value drug-device combination products (per industry reports). Structurally, Consort Medical differs from typical asset managers by operating as a public limited company (PLC) that generates revenue through manufacturing and service contracts rather than deployed capital. Its model is vertically integrated, combining R&D, regulatory expertise, and large-scale production, which provides pharmaceutical clients a single-source solution for complex drug delivery systems. This structural niche positions it as a specialized CDMO within the healthcare value chain.

## Sectors

- Healthcare Services
- Pharmaceuticals
- Medical Devices

## Offices

- Schaffhausen, Switzerland
- New Brunswick, United States
- Guangzhou, China
- Minneapolis, United States
- Basel, Switzerland
- Amsterdam, Netherlands
- Wien, Austria

## People

- Jonathan Glenn — Chief Executive Officer
- Richard Cotton — Chief Financial Officer

## Questions

### Who runs investment decisions at Consort Medical PLC?

Investment strategy at Consort Medical is directed by CEO Jonathan Glenn and CFO Richard Cotton, alongside the board of directors. The company operates as a publicly traded PLC, so capital allocation decisions are subject to shareholder oversight and disclosed in annual reports (per regulatory filings).

### What investment stages does Consort Medical typically target?

Consort Medical does not engage in stage-based investing; instead, it targets partnerships with pharmaceutical companies at any development stage, from early-phase clinical trials to commercial-scale production. Its Bespak and Aesica divisions provide services tailored to both pre-commercial and approved products (per industry documentation).

### Which sectors does Consort Medical explicitly avoid?

Consort Medical focuses exclusively on healthcare and pharmaceutical applications, specifically drug delivery devices and CDMO services. It does not participate in sectors outside of life sciences, such as technology, real estate, or financial services.

### How is Consort Medical related to other entities in the healthcare space?

Consort Medical operates independently as a publicly traded company. It has no disclosed affiliations with family offices or venture capital firms. Its subsidiaries include Bespak and Aesica, both wholly owned operational units that deliver its manufacturing and development services (per public filings).

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/consort-medical-plc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology